These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 8306326)

  • 1. Analysis of the p53 gene and its expression in human glioblastoma cells.
    Van Meir EG; Kikuchi T; Tada M; Li H; Diserens AC; Wojcik BE; Huang HJ; Friedmann T; de Tribolet N; Cavenee WK
    Cancer Res; 1994 Feb; 54(3):649-52. PubMed ID: 8306326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1.
    Albertoni M; Shaw PH; Nozaki M; Godard S; Tenan M; Hamou MF; Fairlie DW; Breit SN; Paralkar VM; de Tribolet N; Van Meir EG; Hegi ME
    Oncogene; 2002 Jun; 21(27):4212-9. PubMed ID: 12082608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
    Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM
    Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitization of rat glioblastoma multiforme to cisplatin in vivo following restoration of wild-type p53 function.
    Dorigo O; Turla ST; Lebedeva S; Gjerset RA
    J Neurosurg; 1998 Mar; 88(3):535-40. PubMed ID: 9488309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.
    Reilly KM; Loisel DA; Bronson RT; McLaughlin ME; Jacks T
    Nat Genet; 2000 Sep; 26(1):109-13. PubMed ID: 10973261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wild type p53 functions as a control protein in the differentiation pathway of the B-cell lineage.
    Aloni-Grinstein R; Zan-Bar I; Alboum I; Goldfinger N; Rotter V
    Oncogene; 1993 Dec; 8(12):3297-305. PubMed ID: 8247532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas.
    Saxena A; Clark WC; Robertson JT; Ikejiri B; Oldfield EH; Ali IU
    Cancer Res; 1992 Dec; 52(23):6716-21. PubMed ID: 1358438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells.
    Matozaki T; Sakamoto C; Suzuki T; Matsuda K; Uchida T; Nakano O; Wada K; Nishisaki H; Konda Y; Nagao M
    Cancer Res; 1992 Aug; 52(16):4335-41. PubMed ID: 1322785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.
    Tada M; Iggo RD; Waridel F; Nozaki M; Matsumoto R; Sawamura Y; Shinohe Y; Ikeda J; Abe H
    Mol Carcinog; 1997 Mar; 18(3):171-6. PubMed ID: 9115587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a human homolog of the Drosophila neuralized gene within the 10q25.1 malignant astrocytoma deletion region.
    Nakamura H; Yoshida M; Tsuiki H; Ito K; Ueno M; Nakao M; Oka K; Tada M; Kochi M; Kuratsu J; Ushio Y; Saya H
    Oncogene; 1998 Feb; 16(8):1009-19. PubMed ID: 9519875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].
    Wang H; Lai B; Li J
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):268-72. PubMed ID: 11326947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human glioblastoma cell growth by WAF1/Cip1 can be attenuated by mutant p53.
    Jung JM; Li H; Kobayashi T; Kyritsis AP; Langford LA; Bruner JM; Levin VA; Zhang W
    Cell Growth Differ; 1995 Aug; 6(8):909-13. PubMed ID: 8547219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of radiation on cytokine and cytokine receptor messenger-RNA profiles in p53 wild and mutated human glioblastoma cell lines.
    Yee D; Hao C; Cheung HC; Chen HT; Dabbagh L; Hanson J; Coupland R; Petruk KC; Fulton D; Roa WH
    Clin Invest Med; 2001 Apr; 24(2):76-82. PubMed ID: 11368149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-Methylcholanthrene inactivates the p53 gene in Syrian hamster embryo fibroblasts by inducing a specific intronic point mutation.
    Albor A; Flessate DM; Soussi T; Notario V
    Cancer Res; 1994 Aug; 54(16):4502-7. PubMed ID: 8044802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic alterations associated with glioma progression.
    Kleihues P; Lübbe J; Watanabe K; von Ammon K; Ohgaki H
    Verh Dtsch Ges Pathol; 1994; 78():43-7. PubMed ID: 7534015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single cell monitoring of growth arrest and morphological changes induced by transfer of wild-type p53 alleles to glioblastoma cells.
    Van Meir EG; Roemer K; Diserens AC; Kikuchi T; Rempel SA; Haas M; Huang HJ; Friedmann T; de Tribolet N; Cavenee WK
    Proc Natl Acad Sci U S A; 1995 Feb; 92(4):1008-12. PubMed ID: 7862624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells. Implication of the tumor suppressor genes for gene therapy.
    Asai A; Miyagi Y; Sugiyama A; Gamanuma M; Hong SH; Takamoto S; Nomura K; Matsutani M; Takakura K; Kuchino Y
    J Neurooncol; 1994; 19(3):259-68. PubMed ID: 7807177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominance of wild-type p53-mediated transcriptional activation in breast epithelial cells.
    Davis P; Bazar K; Huper G; Lozano G; Marks J; Iglehart JD
    Oncogene; 1996 Sep; 13(6):1315-22. PubMed ID: 8808706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor and growth suppression of breast cancer cells by chromosome 17-associated functions.
    Negrini M; Sabbioni S; Haldar S; Possati L; Castagnoli A; Corallini A; Barbanti-Brodano G; Croce CM
    Cancer Res; 1994 Apr; 54(7):1818-24. PubMed ID: 8137297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.